Back to School: How biopharma can reboot drug development. Access exclusive analysis here
In a double-blind trial in 304 evaluable patients, Forteo significantly increased lumbar spine BMD vs. Fosamax alendronate
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury